Evidence map›Paper›PMID 31655421›Full record

ArticleJournal of neuroimmunology2019

Lymphocytic ganglionitis leading to megacolon in lymphocyte-rich glioblastoma.

Jared T Ahrendsen, Kevin R Anderson, Matthew P Anderson

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of neuroimmunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jared T AhrendsenDepartments of Pathology, Harvard Medical School, Boston, MA, USA.
Kevin R AndersonDepartments of Pathology, Harvard Medical School, Boston, MA, USA.
Matthew P AndersonDepartments of Pathology, Harvard Medical School, Boston, MA, USA; Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: mpanders@bidmc.harvard.edu.
Harvard University · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI WOOLF, CLIFFORD J · 1985 to 2015
$26.2M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI WOOLF, CLIFFORD J · 2016 to 2020
$5.2M
VTA VGluT2 Sociability Circuit in Genetic AutismR01MH112714 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SAPER, CLIFFORD B · 2018 to 2022
$2.2M
Neurobiology of Aggression Comorbidity in AutismR01MH114858 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SAPER, CLIFFORD B · 2017 to 2021
$2.2M
NICHD NIH HHS P30 HD018655NICHD NIH HHS U54 HD090255NIMH NIH HHS R01 MH112714NIMH NIH HHS R01 MH114858
6 · The paper itself

Abstract

T-cell immune attack of cancer cells underlies the efficacy of immune checkpoint inhibitors in many cancer subtypes, but is not yet well established in the primary brain cancer glioblastoma. Immune checkpoint inhibitor treatments that disinhibit the immune system to enhance immune clearance of cancer have in rare cases resulted in T-cell attack of peripheral ganglia causing lymphocytic ganglionitis. In glioblastoma, lymphocytic ganglionitis has not been reported and checkpoint inhibitors are not routinely used. Here we report a case of glioblastoma not treated with checkpoint inhibitors in which the primary tumor and peripheral ganglia of the celiac and sympathetic chains, as well as myenteric plexus, are infiltrated by CD8

Indexed as

Brain NeoplasmsFatal OutcomeGanglia, SympatheticGlioblastomaHumansLymphocytesMaleMegacolonMiddle AgedCD8GanglionitisGlioblastomaLymphocyticParaneoplasticT-cell

Identifiers

PMID31655421
PMCPMC6933511
OpenAlexW2981244336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.